Trade Summary

3 days ago, Mohindru Mani, serving as Chief Executive Officer at Cardiff Oncology, Inc. (CRDF), purchased 34,364 shares at $1.46 per share, for a total transaction value of $49,999.62. Following this transaction, Mohindru Mani now holds 59,067 shares of CRDF.

This purchase represents a 139.11% increase in Mohindru Mani's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 14, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 16, 2026 at 4:01 PM ET, 2 days after the trade was made.

Cardiff Oncology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.